Listed

MetaVia Inc.

MTVANasdaqCIK 1638287HealthcareFiscal year ends Dec 31

Reports and events: 278 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

MetaVia Inc., Reports and events
FiledFormWhat it isAccession number
2022-05-1817:13 ETDEF 14AProxy statementPeriod 2022-06-090001140361-22-019809
2022-05-1316:32 ET10-QQuarterly reportPeriod 2022-03-310001558370-22-008767
2022-04-0108:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-004997
2022-03-3117:10 ET10-KAnnual reportPeriod 2021-12-310001558370-22-004958
2022-03-2116:45 ET8-K3.01 Delisting notice0001558370-22-004007
2022-01-2816:41 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001558370-22-000589
2022-01-1417:12 ET8-K5.02 Departure or appointment of officers or directors0001104659-22-004478
2021-11-1508:37 ET10-QQuarterly reportPeriod 2021-09-300001558370-21-015881
2021-11-1508:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-015873
2021-11-1014:17 ETSC 13D/AOwnership report, active investor, amended0000898432-21-000722
2021-11-0408:10 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-134050
2021-10-0416:46 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-122546
2021-09-0116:20 ETSC 13D/AOwnership report, active investor, amended0000899140-21-000623
2021-08-3010:27 ETSC 13D/AOwnership report, active investor, amended0001437749-21-021128
2021-08-3021:11 ETSC 13D/AOwnership report, active investor, amended0000899140-21-000621
2021-08-1816:30 ET8-K5.07 Shareholder vote results0001558370-21-011914
2021-08-1608:24 ET10-QQuarterly reportPeriod 2021-06-300001558370-21-011762
2021-08-1608:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-011759
2021-07-2610:42 ETDEF 14AProxy statementPeriod 2021-08-180001104659-21-095672
2021-07-1208:41 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-21-008852
2021-06-1516:05 ETDEF 14AProxy statementPeriod 2021-07-090001558370-21-008310
2021-05-1717:08 ET10-QQuarterly reportPeriod 2021-03-310001558370-21-007427
2021-05-1717:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-007425
2021-05-1416:36 ET8-K5.02 Departure or appointment of officers or directors0001558370-21-007287
2021-04-3016:39 ET10-K/AAnnual report, amendedPeriod 2020-12-310001558370-21-005423
2021-04-1517:12 ET10-KAnnual reportPeriod 2020-12-310001558370-21-004356
2021-04-1516:58 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-004352
2021-03-2408:15 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-21-003397
2021-03-1506:05 ETSC 13D/AOwnership report, active investor, amended0001437749-21-005982
2021-03-1106:08 ETSC 13DOwnership report, active investor0001104659-21-034702
2021-03-0508:41 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-032424
2021-03-0109:22 ET8-K/A1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-029729
2021-01-2117:03 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-21-000329
2021-01-1309:00 ET8-K5.02 Departure or appointment of officers or directors0001558370-21-000181
2021-01-0816:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-21-000119
2021-01-0616:05 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-21-000051
2020-11-1316:34 ET10-QQuarterly reportPeriod 2020-09-300001558370-20-013826
2020-09-0208:57 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-20-010954
2020-08-1115:37 ET10-QQuarterly reportPeriod 2020-06-300001558370-20-010309
2020-06-1816:01 ET8-K5.07 Shareholder vote results0001558370-20-007610
2020-05-2608:39 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-20-006943
2020-05-2016:46 ET10-QQuarterly reportPeriod 2020-03-310001558370-20-006879
2020-04-2916:10 ETDEF 14AProxy statementPeriod 2020-06-180001047469-20-002703
2020-04-1517:13 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-20-003927
2020-03-3017:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-20-003388
2020-03-3017:21 ET10-KAnnual reportPeriod 2019-12-310001558370-20-003385
2020-02-2016:01 ET8-K/A9.01 Financial statements and exhibits0001558370-20-001074
2020-02-1316:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001558370-20-000773
2020-02-0416:01 ET8-K1.01 Entry into a material agreement0001558370-20-000476
2020-01-2208:52 ET8-K/A9.01 Financial statements and exhibits0001558370-20-000207

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:33 ET. Listed shows no prices and gives no investment advice.